This is also true for small-cell lung cancers where there is limited disease, with or without pleural effusion. Pleural effusions with positive cytology for small-cell lung carcinoma constitute a worse prognosis for patients with otherwise limited disease without malignant effusion (171). In non-small cell lung cancer at an advanced, inoperable stage, talc pleurodesis should be considered (172, 173). Systemic chemotherapy is the treatment of choice in smallcell lung cancer, where the pleural effusion often resolves without the need for local treatment (171). Pleurodesis is indicated only when chemotherapy is contraindicated or ineffective. Mesothelioma Median survival of patients with mesothelioma is between 6 and 18 mo. Unfortunately, the clinical course is not significantly affected by current therapeutic maneuvers. Distant metastatic disease resulting from hematogenous spread may also be present, typically at the end stage (174­176). A more favorable prognosis is associated with epithelial histology, stage I disease (particularly if the disease is localized to the parietal pleura), absence of chest pain, and the presence of symptoms for less than 6 mo before diagnosis (90, 177). High-dose external beam irradiation, intrapleural administration of radioactive isotopes, and various chemotherapeutic regimens have shown no significant effect on overall survival. In spite of careful selection (age 60 yr, early-stage disease, favorable epithelial type), the 5-yr survival rate is only 11% (175, 178, 179). In light of this outlook, there has been ongoing focus on multimodality therapy (180, 181). A combination of parietal pleurectomy with postoperative intrapleural therapy and or external beam irradiation resulted in median survival of 22. In stage I, and especially in stage Ia (without involvement of the visceral pleura), the disease is still intrapleural and thus can be treated by intrapleural therapy. The best indication for intrapleural treatment is stage Ia (or Ib) in epithelial-type mesothelioma, with nodules or thickening not greater than 5 mm, in patients whose general status is still good. One is a multimodality treatment, including radical surgery, radiation therapy, and chemotherapy; the result of this approach is largely related to the expertise and experience of the involved surgeons, so that a surgical mortality rate as low as possible (range, 4 to 8%) is maintained. The second is medical treatment: talc pleurodesis if necessary, preventive radiation therapy, and combined chemotherapy (183). Breast Carcinoma noma develop a malignant pleural effusion during the course of the disease (4­6). In 43% of those patients, the effusion is the first symptom of metastatic disease (6); the time from initial diagnosis until the development of pleural effusion averages 41. In a review of seven autopsy series, the pleura was affected in about one-half of 2,050 cases (range, 36 to 65%) (10). Higher tumor stages at the time of initial diagnosis (136), as well as chest wall recurrences (6), were associated more often with pleural effusion. Besides the rare direct invasion through the chest wall, the pathogenesis of pleural involvement in breast carcinoma is through either lymphatic or hematogenic spread. Fentiman and colleagues found, in 99 patients with unilateral breast tumors and pleural effusions, that 50% of the effusions were ipsilateral, 40% were contralateral, and 10% were bilateral (137); Raju and Kardinal, however, observed ipsilateral effusions in 85 of 122 patients (184). The yield from cytologic examination of the effusion is usually higher than with other tumors (185), so that pleural biopsy or medical thoracoscopy is rarely indicated. Determination of hormone receptor status in the pleural tissue may be helpful in guiding hormonal therapy (94). In differential diagnosis, it is important to exclude pleural effusions caused by postoperative radiotherapy, which usually occur during the first 6 mo and are commonly accompanied by radiation pneumonitis; they usually resolve spontaneously over several months (186). Recommended treatment of metastatic pleural effusion with breast carcinoma differs from that for other tumor types. Chemotherapy with cytotoxic agents and or hormones may be effective (137, 187, 188). If those approaches do not relieve symptoms, local treatment options must be considered. Median survival after the appearance of metastatic pleural effusions in one series of 105 patients was 13 mo (range, 0­72 mo), without taking into consideration the different treatment modalities and other factors (137). Raju and Kardinal, in their study of 122 patients cited above (184), observed a median survival of only 6 mo after the onset of pleural effusion. Survival times are undoubtedly strongly related to the presence of additional metastatic manifestations; in another study, median survival of patients whose pleural effusions were the only evidence of recurrent malignancy (n 10) was 48 mo, whereas median survival of those with other evident sites of disseminated disease (n 35) was only 12 mo (188). Lymphoma, Leukemia, and Multiple Myeloma Breast carcinoma is the second-ranking cause of malignant pleural effusion. About 7 to 11% of patients with breast carci- Approximately 10% of malignant pleural effusions are due to lymphoma. Pleural effusion usually develops in the later stages of the disease, with dyspnea the chief symptom in 63% (9); rarely, it may be the only symptom (191). The effusion is usually an exudate but may rarely have transudative characteristics. Chromosome analysis has high sensitivity, about 85% (198); results obtained by medical thoracoscopy are superior (58, 191). Effusions can also result from radiation of the mediastinum or from obstruction of lymphatic drainage of the pleural space due to mediastinal fibrosis, constrictive pericarditis, or superior vena caval obstruction. This may occur a year or two after radiotherapy (199) and may also result in a chylous effusion (200). Average survival time after the first thoracentesis is short, 6 or 7 mo, but there may be a wide range (7, 41). The presence of malignant cells in the effusion is associated with a poor prognosis. Pleurodesis by talc poudrage combined with parenteral alimentation, in order to reduce chyle production, may be necessary when chemotherapy fails (201). Mediastinal radiation may be useful when there is mediastinal node involvement and may be effective in chylothorax (195). In patients with chylothorax, pleuroperitoneal shunt may be a good approach in failed therapy, as it can recirculate the chyle (202). Multiple myeloma is an infrequent cause of malignant pleural effusion, which occurs in about 6% of cases (189, 203). High pleural protein values, in the range of 8­9 g L, are suggestive of this diagnosis. Electrophoresis and immunoelectrophoresis of pleural fluid may be diagnostically characteristic (204). Infiltration of the chest wall is usually present, due to invasion from adjacent skeletal lesions (ribs, sternum, and vertebrae), but pleuropulmonary infiltration may also originate from soft tissue plasmocytoma of the chest wall or from direct involvement. Long-term relief of symptoms related to the effusion, with absence of fluid reaccumulation on chest radiographs until death Partial success. Data should be reported with and without inclusion of patients who die within 1 mo of pleurodesis. Prospects for Clinical Studies There are few data on which the clinician can confidently rely in making important therapeutic decisions in the management of malignant pleural effusions. Determine the course of small, asymptomatic malignant pleural effusions with and without treatment. Because late pleurodesis attempts are more likely to fail than earlier interventions, it might be suggested that pleurodesis simply be performed at an early stage, once the malignant nature of the effusion is known. Many of these patients, however, have few symptoms attributable to the effusion itself and are not likely to seek relief or treatment for it. Prospective studies are therefore needed to provide reliable management guidelines. Assess talc slurry pleurodesis versus talc poudrage via thoracoscopy, with particular attention to optimal dosage, the use of intrapleural analgesics such as lidocaine, and patient positioning during talc slurry procedures. Explain the systemic complications and side effects of talc pleurodesis, especially potential triggering of coagulation in the systemic circulation. Because it is likely that this untoward event occurs with other sclerosing agents as well, such information would be useful in developing preventive measures. Explore and clarify the potential role of intrapleural therapeutic interventions, including not only chemotherapeutic agents but also such immune modulators as cytokines and interferon. As observed in the earlier discussion of this topic, employment of this modality has been largely hit-and-miss; randomized studies are needed to determine optimal application of agents both singly and in combination and the effect of various approaches on survival. Markers that would help the clinician differentiate, for example, between reactive mesothelial cells, mesotheliomas, and metastatic adenocarcinomas would be especially valuable. However, a meta-analysis of more than 400 patients found a poor predictive value for success of pleurodesis (52). Because pleural fluid glucose is usually more sensitive to fluctuations in serum than pH, the predictive value of glucose is lower than that of pH. In one prospective study, measurement of the elastance of the pleural space was associated with pleurodesis outcome (107). Quality of life of patients with malignant effusions should be evaluated with regard to those symptoms that are related to the effusion itself. Ideally, therapy should minimize discomfort, as well as limit hospitalization time, in these patients with an often limited life span. However, an important aspect in any treatment is prevention of reoccurrence of the symptomatic effusion. Finally, pain relief is another important quality-of-life issue, which must be addressed. This is particularly true for patients with mesothelioma, whose primary complaint is often pain instead of dyspnea. The following definitions are proposed: In the absence of other effective, nontoxic therapies for malignant mesothelioma, several groups of investigators have turned to the newly evolving technology of gene therapy for new treatment modalities (206, 20). The malignant pleural effusion: a review of cytopathological diagnoses of 584 specimens from 472 consecutive patients. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusions: analysis of 414 cases. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis. The incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia. Mechanism of relief of dyspnea after thoracentesis in patients with large pleural effusions. Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients. Complications associated with thoracentesis: a prospective randomized study comparing three different methods. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Relationship between cell type, glucose concentration, and express viral thymidine kinase and conveying sensitivity to the normally nontoxic antiviral drug ganciclovir. Further development of therapeutic trials for the treatment of localized malignancy is warranted (206, 207). Pleural metastases with malignant effusions are common to many neoplasms, but the mechanisms of localization to the pleura remain poorly understood. Although mechanisms by which neoplastic invasiveness and metastases have been extensively studied, the particular intracellular events that lead to pleural metastases are poorly understood. Many systems may influence remodeling of the neoplastic stroma and neoplastic growth in the pleural compartment. In particular, the procoagulant and fibrinolytic systems have been linked to the spread of malignant mesothelioma (208, 209). The urokinase­urokinase receptor system has been shown to relate to the invasiveness of malignant mesothelioma cells (210, 211), recapitulating the findings in several other types of cancer. Other systems are no doubt crucial to the development and propagation of pleural malignancies and these remain to be elucidated. Understanding the mechanisms propelling metastases to the pleura and their growth is essential if effective therapy is to be developed. Instillation of a sclerotic agent into the pleural space of a patient with malignant pleural disease involves intimate and immediate contact of the sclerosing agent with both normal mesothelial cells lining the surface of the pleural cavity and the invading malignant cells. Rapid changes in the pleural fluid cellular and cytokine milieu ensue, leading to either success or failure of pleurodesis. The balance of factors that predispose the patient for success or failure of pleurodesis needs to be clearly defined. Several sclerotic agents, including some nonchemotherapeutic agents, may have a direct effect on the malignant tumor cells, such as initiation of the events leading to programmed cell death (apoptosis) of the tumor cell. This Statement was developed by an ad hoc subcommittee of the Assembly on Clinical Problems. Pleural metastatic tumours and effusions: frequency and pathogenic mechanisms in a post-mortem series. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Low glucose and pH levels in malignant effusions; diagnostic significance and prognostic value in respect to pleurodesis. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Malignant pleural effusions: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis.

Additional information:

• Flavoxate
• Duloxetine
• Amiodarone

To facilitate administration of the drug by the selected routes, appropriate dosage forms, such as tablets, capsules, injections, suppositories, ointments, aerosols, and others, are formulated and prepared. In addition to the active therapeutic ingredients, a pharmaceutical formulation contains a number of nontherapeutic or pharmaceutical ingredients. Pharmaceutical ingredients include such materials as fillers, thickeners, solvents, suspending agents, tablet coatings and disintegrants, penetration enhancers, stabilizing agents, antimicrobial preservatives, flavors, colorants, and sweeteners. To ensure the stability of a drug in a formulation and the continued effectiveness of the drug product throughout its usual shelf life, the principles of chemistry, physical pharmacy, microbiology, and pharmaceutical technology must be applied. Finally, the product must be effectively packaged and clearly and completely labeled according to legal regulations. The medication must be taken in sufficient quantity, at specified intervals, and for an indicated duration to achieve the desired therapeutic outcomes. Before initially taking a medication, a patient should be advised of any expected side effects and of foods, beverages, and/or other drugs that may interfere with the effectiveness of the medication. Through professional interaction and communication with other health professionals, the pharmacist can contribute greatly to patient care. An intimate knowledge of drug actions, pharmacotherapeutics, formulation and dosage form design, available pharmaceutical products, and drug information sources makes the pharmacist a vital member of the health care team. The pharmacist is entrusted with the legal responsibility for the procurement, storage, control, and distribution of effective pharmaceutical products and for the compounding and filling of prescription orders. Drawing on extensive training and knowledge, the pharmacist serves the patient as an advisor on drugs and encourages their safe and proper use through patient counseling. Human disease and the instinct to survive have led to their discovery through the ages. From experience, early humans would learn that certain therapy was more effective than others, and from these beginnings came the practice of drug therapy. From the earliest records, the primary methods of removing spirits were through the use of spiritual incantations, the application of noisome materials, and the administration of specific herbs or plant materials. The art of the apothecary has always been associated with the mysterious, and its practitioners were believed to have connection with the world of spirits and thus performed as intermediaries between the seen and the unseen. The compassion of a god, the observance of ceremonies, the absence of evil spirits, and the healing intent of the dispenser were individually and collectively needed to make the drug therapeutically effective. Because of this, the tribal apothecary was one to be feared, respected, trusted, sometimes mistrusted, worshiped, and revered, for it was through his potions that spiritual contact was made, and upon that contact the cures or failures depended. As time passed, the art of the apothecary combined with priestly functions, and among the early civilizations, the priest­magician or priest­physician became the healer of the body as well as of the soul. Numerous ancient tablets, scrolls, and other relics as early as 3000 bc have been uncovered and deciphered by archaeologic scholars to the delight of historians of both medicine and pharmacy; these ancient documents are specific associations with our common heritage. Perhaps the most famous of these surviving memorials is the Ebers papyrus, a continuous scroll some 60 ft long and a foot wide dating to the 16th century bc. This document, which is now preserved at the University of Leipzig, is named for the noted German Egyptologist Georg Ebers, who discovered it in the tomb of a mummy and partly translated it during the last half of the 19th century. The drugs are chiefly botanical, although mineral and animal drugs are also noted. Such botanical substances as acacia, castor bean (from which we express castor oil), and fennel are mentioned along with apparent references to such minerals as iron oxide, sodium carbonate, sodium chloride, and sulfur. Notable among those whose genius and creativeness had a revolutionary influence on the development of pharmacy and medicine were Hippocrates (ca. Because of his pioneering work in medical science and his inspirational teachings and advanced philosophies that have become a part of modern medicine, Hippocrates is honored by being called the Father of Medicine. Dioscorides, a Greek physician and botanist, was the first to deal with botany as an applied science of pharmacy. This area of study is today known as natural products chemistry and/or pharmacognosy, a term formed from two Greek words, pharmakon, drug, and gnosis, knowledge. Some of the drugs Dioscorides described, including opium, ergot, and hyoscyamus, continue to have use in medicine. His descriptions of the art of identifying and collecting natural drug products, the methods of their proper storage, and the means of detecting adulterants or contaminants were the standards of the period, established the need for additional work, and set guidelines for future investigators. Claudius Galen, a Greek pharmacist­physician who attained Roman citizenship, aimed to create a perfect system of physiology, pathology, and treatment. His medical writings include descriptions of numerous drugs of natural origin with a profusion of drug formulas and methods of compounding. He originated so many preparations of vegetable drugs by mixing or melting the individual ingredients that the field of pharmaceutical preparations was once commonly referred to as "Galenic pharmacy. Between that time and the evolution of chemistry as an exact science, pharmacy and chemistry became united as pharmacy and medicine had been. Perhaps no person in history exercised such a revolutionary influence on pharmacy and medicine as did Aureolus Theophrastus Bombastus von Hohenheim (1493­1541), a Swiss physician and chemist who called himself Paracelsus. He believed it was possible to prepare a specific medicinal agent to combat each specific disease and introduced a host of chemical substances to internal therapy. The opportunity was presented for the investigation of medicinal materials on a firm scientific basis, and the challenge was accepted by numerous pharmacists who conducted their research in the back rooms and basements of their pharmacies. Noteworthy among them was the Swede Karl Wilhelm Scheele (1742­1786), perhaps the most famous of all pharmacists because of his scientific genius and dramatic discoveries. Among his discoveries were the chemicals lactic acid, citric acid, oxalic acid, tartaric acid, and arsenic acid. The isolation of morphine from opium by the German pharmacist Friedrich Sertürner (1783­1841) in 1805 prompted a series of isolations of other active materials from medicinal plants by a score of French pharmacists. Contemporary examples of drugs isolated from a natural source include paclitaxel (Taxol), an agent with antitumor activity derived from the Pacific yew tree (Taxus baccata) and employed in the treatment of metastatic carcinoma of the ovary; vincaleukoblastine, another antineoplastic drug, from Vinca rosea; and digoxin, a cardiac glycoside, from Digitalis lanata. Throughout Europe during the late 18th century and the beginning of the 19th century, pharmacists like Pelletier and Sertürner were held in great esteem because of their intellect and technical abilities. The extraction and isolation of active constituents from crude (unprocessed) botanical drugs led to the development of dosage forms of uniform strength containing singly effective therapeutic agents of natural origin. Although many of the drugs indigenous to America and first used by the American Indians were adopted by the settlers, most drugs needed in this country before the 19th century were imported from Europe, either as the raw materials or as finished products. With the Revolutionary War, however, it became more difficult to import drugs, and the American pharmacist was stimulated to acquire the scientific and technologic expertise of his European contemporary. From this period until the Civil War, pharmaceutical manufacture was in its infancy in this country. Organized sets of monographs or books of these standards are called pharmacopeias or formularies. From that time on countless city, state, and national pharmacopeias were published by various European pharmaceutical societies. For convenience and because of their familiarity with them, colonial physicians and apothecaries used the pharmacopeias and other references of their various homelands. It was a 32-page booklet containing information on 84 internal and 16 external drugs and preparations. During the last decade of the 18th century, several attempts were made by various local medical societies to collate drug information, set appropriate standards, and prepare an extensive American pharmacopeia of the drugs in use at that time. Included were monographs on many drugs indigenous to America, which were not described in the European pharmacopeias of the day. He proposed dividing the United States as then known into four geographic districts-northern, middle, southern, and western. The plan provided for a convention in each of these districts, to be composed of delegates from all medical societies and medical schools within them. Where there was as yet no incorporated medical society or medical school, voluntary associations of physicians and surgeons were invited to assist in the undertaking. At the general convention, the four district pharmacopeias were to be compiled into a single national pharmacopeia. It should likewise distinguish those articles by convenient and definite names, such as may prevent trouble or uncertainty in the intercourse of physicians and apothecaries (1). As many new drugs entered use, the need for more frequent issuance of standards became increasingly apparent. In 1830 and again in 1840, prominent pharmacists were invited to assist in the revision, and in recognition of their contributions pharmacists were awarded full membership in the convention of 1850 and have participated regularly ever since. Of the seven elected members of the board of trustees, at least two must be representatives of the medical sciences, two others must be representatives of the pharmaceutical sciences, and at least one must be a public member. The individual pharmacist seemed fulfilled as he applied his total art to the creation of elegant pharmaceutical preparations from crude botanical materials. It was a time that would never be seen again because of the impending upsurge in technologic capabilities and the steady development of the basic sciences, particularly synthetic organic chemistry. The steam engine, which used water power to turn mills that powdered crude botanical drugs, was replaced by the gas, diesel, or electric motor. New machinery was substituted for the old whenever possible, and often machinery from other industries was adapted to the special needs of pharmaceutical manufacturing. Mixers from the baking industry, centrifugal machines from the laundry industry, and sugarcoating pans from the candy industry were a few examples of improvisations. The isolation of some active constituents of plant drugs led to the knowledge of their chemical structure. In 1872, the synthesis of salicylic acid from phenol inaugurated the synthesis of a group of analgesic compounds including acetylsalicylic acid (aspirin), which was introduced into medicine in 1899. This new source of drugs-synthetic organic chemistry- welcomed the turn into the 20th century. Until this time, drugs created through the genius of the synthetic organic chemist relieved a host of maladies, but none had been found to be curative-none, that is, until 1910, when arsphenamine, a specific agent against syphilis, was introduced to medical science. This was the start of an era of chemotherapy, an era in which the diseases of humans became curable through the use of specific chemical agents. The concepts, discoveries, and inspirational work that led mankind to this glorious period are credited to Paul Ehrlich, the German bacteriologist who together with a Japanese colleague, Sahachiro Hata, discovered arsphenamine. Today most of our new drugs, whether they are curative or palliative, originate in the flask of the synthetic organic chemist. The first edition was published in 1888 under the title National Formulary of Unofficial Preparations (3). After that date, new editions appeared every 5 years, with supplements issued periodically as necessary. The term "products" is now generally used to refer to manufactured drugs and "preparations" to compounded drugs. Included in this group are pharmacists, physicians, dentists, veterinarians, nurses, producers, and suppliers of bulk chemicals for use in drug production, large and small manufacturers of pharmaceutical products, drug procurement officers of various private and public health agencies and institutions, drug regulatory and enforcement agencies, and others. This monograph demonstrates the type of information that appears for organic medicinal agents. The initial part of the monograph consists of the official title (generic or nonproprietary name) of the drug substance. Appearing next in the monograph is a statement of chemical purity, a cautionary statement that reflects the toxic nature of the agent, packaging and storage recommendations, and chemical and physical tests, and the prescribed method of assay to substantiate the identification and purity of the chemical. In each monograph, the standards set forth are specific to the individual therapeutic agent, pharmaceutical material, or dosage form preparation to ensure purity, potency, and quality. Over the years, a number of countries have published their own pharmacopeias, including the United Kingdom, France, Italy, Japan, India, Mexico, Norway, and the former Union of Soviet Socialist Republics. The Mexican pharmacopeia (Farmacopea de los Estados Unidos Mexicanos) is the only other actively maintained pharmacopeia in this hemisphere (7). The law required drugs marketed interstate to comply with their claimed standards for strength, purity, and quality. The then-new wonder drug sulfanilamide, which was not soluble in most common pharmaceutical solvents of the day, was prepared and distributed by an otherwise reputable manufacturer as an elixir using as the solvent diethylene glycol, a highly toxic agent used in antifreeze solutions. The necessity for proper product formulation and thorough pharmacologic and toxicologic testing of the therapeutic agent, pharmaceutical ingredients, and the completed product was painfully recognized. Although the act of 1938 required manufactured pharmaceutical products to be safe for human use, it did not require them to be efficacious. Many drugs that had been on the market prior to this Act were allowed to remain on the market if their formula was unchanged and they were "grandfathered" in. Other drugs that are considered useful only after expert diagnosis or too dangerous for use in self-medication are made available to the patient only by prescription. These drugs must bear the symbol "Rx Only" or the legend "Caution: Federal Law Prohibits Dispensing Without Prescription. Examples of such drugs include ibuprofen, ketoprofen, cimetidine, loratadine, and ranitidine. The refill status of prescriptions for certain legend drugs known to be subject to public abuse was further regulated with the passage of the Drug Abuse Control Amendments of 1965 and then by the Comprehensive Drug Abuse Prevention and Control Act of 1970. It was a drug of special interest because of its apparent lack of toxicity even at extreme dosage levels. It was hoped that it would replace the barbiturates as a sedative and therefore prevent the frequent deaths caused from accidental and intentional barbiturate overdosage. Thalidomide given to women during pregnancy produced birth defects, most notably phocomelia, an arrested development of the limbs of the affected newborn. This drug catastrophe spurred the Congress to strengthen the existing laws regarding new drugs. Without dissent, on October 10, 1962, the Kefauver-Harris Drug Amendments to the Food, Drug, and Cosmetic Act of 1938 were passed by both houses of Congress. These schedules provide for decreasing levels of control, from schedule I to schedule V. In this category are morphine, cocaine, methamphetamine, amobarbital, and other such drugs. In this category are specified quantities of codeine, hydrocodone, and similar agents.

Rheumatism Root (Wild Yam). Lexapro.

• Hot flashes and night sweats associated with menopause, when wild yam cream is applied to the skin.
• What is Wild Yam?
• Are there safety concerns?
• How does Wild Yam work?
• Dosing considerations for Wild Yam.

Source: http://www.rxlist.com/script/main/art.asp?articlekey=96931

As pain is the most common complication associated with doxycycline pleurodesis, narcotic analgesic and or conscious sedation is often recommended (126). Most of these studies demonstrated similar or higher success rates when utilizing bleomycin as a sclerosing agent, compared with tetracycline (117, 128, 129). A direct study comparing doxycycline with bleomycin pleurodesis utilizing small-bore catheter demonstrated similar success rates (72% with bleomycin, 79% with doxycycline) (120). As stated previously, direct studies comparing talc and bleomycin have demonstrated a superior pleurodesis success rate with talc (115, 116, 130). An important criticism of bleomycin as a sclerosing agent involves its relative expense as compared with other sclerosing agents such as talc or doxycycline (129, 131). However, studies utilizing small-bore catheters and bleomycin have demonstrated successful pleurodesis (120, 121) and therefore a potential overall cost savings when factors such as hospitalization, duration, and procedure costs are included. Talc from chemical supply houses is asbestos free (132), with variable particle size generally 50 m. Although talc is not packaged sterilely by the manufacturer, limitation of the number of microorganisms is a part of the specifications and the total bacterial count cannot exceed 500 organisms per gram of talc. In one study, bacillus species were cultured from six different supplies of unsterilized talc; dry heat, irradiation, and ethylene oxide gas all proved effective sterilization methods (133). The cost of sterilizing a 5-g packet of talc (about 10 cm3) is approximately $5, $8, or $16 for dry heat, ethylene oxide, and irradiation, respectively (114). Sterilized talc remains culture negative on the pharmacy shelf for at least 1 yr (134). A review of published series found a 93% success rate (153 of 165 patients) for talc pleurodesis in the treatment of pleural effusions, the majority of them malignant (115). Success was variably defined in these studies but was based primarily on clinical criteria or radiographic findings. In some studies, complete and persistent absence of fluid was the determinant, whereas in others the lack of need for further pleural drainage was the sole criterion. Follow-up times were also variable, and in these studies, doses ranged from 1 to 14 g. When analyzed by method of administration, poudrage and slurry pleurodesis American Thoracic Society 1993 methods resulted in similar success rates of 91%: 418 of 461 for talc poudrage, 168 of 185 for slurry (116­118, 135­137). A large randomized multicenter trial addressing the efficacy of talc poudrage versus talc slurry is near completion in the North American Cooperative Oncology Groups. A defined rate of clinically important complications was observed with thoracoscopic talc poudrage and no deaths were related to the procedure in a series of 360 patients (139). A similarly low rate of complications was observed by Viallat and coworkers, who used either local anesthesia plus conscious sedation or general anesthesia in a two-center study that included 360 patients (140). Fever characteristically occurs 4 to 12 h after talc instillation and may last for 72 h. Empyema has been reported with talc slurry in 0 to 11% of procedures, whereas talc poudrage is associated with an incidence rate of 0 to 3% of patients (141). Local site infection is uncommon, and the degree of pain associated with talc has reportedly ranged from nonexistent to severe. Cardiovascular complications such as arrhythmias, cardiac arrest, chest pain, myocardial infarction, or hypotension have been noted; whether these complications result from the procedures or are related to talc per se has not been determined. It is doubtful that the method of administration (poudrage versus slurry) plays a major role in the development of respiratory failure, although the dose and particle size of talc may be important. In an experimental study using talc slurry, Kennedy and coworkers found prominent perivascular infiltrates with mononuclear inflammation in the underlying lung, and it was speculated that mediators might spread through the pulmonary circulation after application of the sclerosing agent (142). Other possible causes of acute respiratory failure with talc pleurodesis include sepsis due to unsterile or endotoxin-containing talc, excessive talc dosing, active air leak, excessive periprocedure medications, severe underlying lung disease, and re-expansion pulmonary edema. Twenty-two to 35 yr after talc poudrage of pneumothorax, total lung capacity averaged 89% of predicted in 46 patients, whereas total lung capacity was 97% of predicted in 29 patients treated with tube thoracostomy alone (143). None of the poudrage group developed mesothelioma over the 22- to 35-yr follow-up. Although talc poudrage may result in minimally reduced total capacity, as well as pleural thickening on chest radiograph, these changes appear to be clinically unimportant. Short-term follow-up after talc poudrage for pneumothorax revealed no difference in lung function when compared with other patients who had thoracotomy without talc poudrage (144, 145). A link between talc and cancer has been reported in those who mine and process talc (146), but this association is attributed to asbestos, which is commonly found with talc, rather than to talc itself. No increase in lung cancers was found in a group of patients who had talc pleurodesis for pneumothorax and had long-term follow-up (147). Talc is an inexpensive and highly effective pleurodesis agent when administered by either poudrage or slurry in patients with malignant pleural effusions. Development of respiratory failure is reported and may be related to dose and particle size, or other factors related to its instillation (148, 149). Investigation of this issue is ongoing and physicians and patients should be aware of a potential for respiratory failure, which has not been described with other agents. Long-term safety does not appear to be an issue with the asbestos-free product, especially in patients with malignant pleural effusions. Because the response to talc has not been studied over a wide dose range and serious adverse effects tend to occur with higher doses (150), we recommend that no more than 5 g of talc be used and that bilateral simultaneous pleurodesis not be attempted. The most widely reported method of talc instillation into the pleural space for malignant effusion is talc poudrage, which is usually performed under thoracoscopic guidance. Several technical details should be taken into account in order to achieve good pleurodesis and avoid complications. Removal can be easily accomplished during thoracoscopy, as air is passively entering the pleural cavity, thus creating a desirable equilibrium in pressures. Complete collapse of the lung is important, affording a good view of the pleural cavity and the opportunity to biopsy suspicious lesions and also permitting wide distribution of the talc. Although an optimal dose of talc for poudrage has not been established, about 5 g (8­12 ml) is usually recommended for malignant effusions. After talc insufflation, repeat inspection of the pleural cavity should be done to ensure that the powder has been evenly distributed over the pleural surface. Graded and progressive suction should be applied and maintained until the amount of fluid aspirated per day is less than 100 ml. Air leak can occur in patients with necrotic tumor nodules in the visceral pleura, especially those with prior chemotherapy, even if no biopsies of this area have been taken. On average, reported success with talc poudrage is greater than 90% but, as previously noted, reliable guidance on doses remains elusive, and definitions of success have not been standardized (151, 152). Talc slurry is also an effective pleurodesis agent in malignant effusions (136, 138). Potential disadvantages of slurry include lack of uniform distribution; accumulation in dependent areas of the pleural space, possibly leading to incomplete pleurodesis and loculations; and decreased direct contact time with the pleural surface, due to the liquid suspension, with subsequent decrease in effectiveness. The slurry is made by mixing talc with normal saline and gently agitating; various volumes of saline have been used, ranging from 10 to 250 ml (136, 138). We recommend administration of small doses of an intravenous narcotic and anxiolytic-amnestic agent before the procedure. Standard chest tubes (18­24F) or small-bore catheters (10­12F) have been used successfully for talc slurry pleurodesis (123, 124). A dose of 4­5 g of talc in 50 ml of normal saline should be instilled through the chest tube when the radiograph demonstrates an absence or minimal amount of pleural fluid and complete lung expansion. It is unclear whether talc slurry disperses as rapidly throughout the pleural space, compared with tetracycline (154, 155). Therefore, patient rotation is recommended until definitive studies are available. If, after 48 to 72 h, chest tube drainage remains excessive (250 ml/24 h), talc instillation at the same dose used initially should be repeated. Treatment of Pleurodesis Failure Initial failure of pleurodesis can occur as a result of suboptimal techniques or inappropriate patient selection. Recurrence after pleurodesis is unusual with talc but does occur occasionally, usually early after attempted pleurodesis. When initial pleurodesis for malignant pleural effusion fails, several alternatives may be considered. Repeat pleurodesis may be performed either with instillation of sclerosants through a chest tube or by thoracoscopy and talc poudrage. Repeat thoracentesis would be the choice for a terminal patient with short expected survival. In patients with symptomatic malignant pleural effusions due to tumors likely to respond to chemotherapy, such as small-cell lung cancer, systemic treatment should be started if no contraindications exist; it may be combined with therapeutic thoracentesis or pleurodesis. Neoplasms that tend to be chemotherapy responsive include breast cancer (hormone treatment may also be appropriate), small-cell lung cancer, and lymphoma. Effusions associated with prostate, ovarian, thyroid, and germ-cell neoplasms may also be chemotherapy responsive. When systemic treatment options are unavailable or contraindicated, or systemic treatment is or has become ineffective, local therapy such as pleurodesis may be applied. Major surgical procedures, such as parietal pleurectomy, decortication, or pleuropneumonectomy, performed alone have proved to provide neither superior palliation nor prospects for cure compared with pleurodesis alone. Pleurodesis may fail if there is a cortex of malignant tissue covering the pleural surfaces; that cortex may be removable by converting to an open thoracotomy, and pleurodesis may then prove possible. This procedure has a reported perioperative mortality of 12%, and therefore patient selection is important (157). If expansion of the lung is inadequate after removal of an effusion due to a cortex of malignant tissue or fibrosis, a pleuroperitoneal shunt should be inserted. Such a situation may be suggested by lack of mediastinal shift on perioperative radiographs or may be seen only at surgery. Shunt complications, chiefly occlusion, will occur in 12% of patients, and such occlusion is treated by shunt replacement (158), unless infection is confirmed; in that case, long-term drainage with a chest tube is indicated. The possibility of inducing peritoneal seeding with a pleuroperitoneal shunt is a potential risk but has not been convincingly documented, and in this group of patients, there is no established alternative treatment. When the malignancy is localized in the pleural cavity, intrapleural chemotherapy may treat the underlying neoplasm in addition to controlling the effusion (159, 160). To obtain maximal anticancer activity with minimal systemic side effects, however, a high intrapleural concentration with minimal systemic spread of the antineoplastic agent is required. To meet these requirements, several authors have proposed including cytostatic drugs in poly-L-lactic acid microspheres (161). It is not clear whether the observed responses are due to intrinsic sclerosing activity or, instead, to an immunologic effect such as an increased natural killer cell population. There are few studies using endoscopic staging for malignancy involving the pleura (164). Other potential candidates for intrapleural therapy include patients with malignant effusion and an unknown primary tumor. Many of these tumors probably originate from small subpleural carcinomas (168), a condition sometimes termed "pseudomesotheliomatous carcinoma of the lung. Malignant effusions are observed in 7 to 15% of all bronchogenic carcinomas at some time during the course of the illness (2, 3, 13, 169). Effusions occur with all histologic types, most frequently with adenocarcinoma (12, 87). The presence of pleural effusion typically signals an advanced stage of disease and is therefore associated with poor prognosis. These accompanying paramalignant effusions are due to postobstructive pneumonia or atelectasis, venous obstruction by tumor compression, or lymphatic obstruction by mediastinal lymph nodes, and are not associated with direct pleural involvement. The prognosis of patients with non-small cell lung cancer and paramalignant effusion is comparable to that for those in the same stage without pleural effusion (87, 169). The value of multiple preparations in the diagnosis of malignant pleural effusions. Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions: intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy. Mentintas M, Ozdemir N, Solak M, Artan S, Ozdemir M, Basaran N, Ekici M, Erginel S. Cheromosome analysis in pleural effusions: efficiency of this method in the differential diagnosis of pleural effusions. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Significance of epithelial membrane antigen in the work-up of problematic serous effusions. Identification of carcinoma cells in ascitic and pleural fluid: comparison of four panepithelial antigens with carcinoembryonic antigen. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. Athanassiadou P, Athanassiades P, Lazaris D, Kyrkou K, Petrakakou E, Aravantinos D. The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Thoracoscopy: a safe accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Lung cancer and pleural effusion: clinical significance and study of pleural metastatic locations. Cantó A, Arnau A, Galbis J, Martín E, Guijarro R, Fernández A, Martínez P, Martorell M, Pareja E, García-Aguado R, Rico G. The socalled malignant pleural effusion: a new review of direct data obtained with diagnostic pleuroscopy.

Usage: t.i.d.

This ability to modify is referred to as cortical plasticity, or more broadly the neural plasticity. There are three known major circumstances of neural plasticity: (1) postnatal modifications, (2) changes as a consequence to injury to the brain, and (3) the plasticity during learning or experience. Postnatal Development Postnatal modifications of neuronal connectivity occur as a result of interactions with the environment. Environ mental effects affect development and alteration of many neural connections. During this early phase of development, many neural changes occur, changes in cellular, axonal and synaptic parts of the neuron. Number of synapses increases during development until maximum levels are gradually reached in early adulthood. Critical period: the developmental neuroplasticity exhibit an early critical period of development during which neuronal connections are sensitive or plastic to environmental influences. Limbic Dysfunctions Limbic dysfunctions, especially emotional shallowness occurs in prefrontal lesion. Personality Changes Lack of initiative and inability to assess personal performance are striking changes in personality in frontal lobe lesion. Other features are tactlessness, change in social habits, impaired concentration, disturbance in judgment, and tendency toward irresponsible behavior. Response to Injury in Adult Brain In poikilothermic vertebrates, axons in the central nervous system if damaged, show enormous capacity to regenerate. In homeothermic vertebrates, regeneration mainly occurs in the peripheral nervous system. For example, the phenomenon of axonal sprouting that occurs following spinal transection. Axonal sprou ting also occurs in other structures in central nervous system, including hippocampus, septum, cerebellum and red nucleus. For example, the cerebellar projection to red nucleus is preferentially to the soma and proximal dendrites of the neurons, whereas the cortical projection to red nucleus primarily ends on distal dendrites. If the cerebellar efferent fibers to red nucleus are damaged, then the cortical projection fibers sprout to establish more proximal connections at the synaptic sites that have been vacated by degeneration of the cerebellorubral fibers. These new connections increase the influence of the motor cortex on the red nucleus and contribute to the recovery of motor function. Prefrontal Lobotomy and Frontal Lobe Syndrome When the connection of thalamus with prefrontal lobe is cut (this is called prefrontal lobotomy), the major areas of prefrontal lobe (areas 8­12, 44­47) are disconnected. Sense of well-being (euphoria), and failure to understand the seriousness of others feeling. Occipital Lobe this is the area of the brain posterior to the parietooccipital sulcus. It contains area 17 (the primary visual cortex), and 18 and 19 (the association visual cortex or higher order of visual cortex). The neural connections are determined genetically, and 1154 Section 11: Neurophysiology 4. Change in synaptic connections and cellular changes are the bases of learning and memory. Learning and Memory the capacity of certain neurons to change their behavior as a function of environmental inputs is a very important property of the nervous system. Dominant (categorical) hemisphere is associated with language function, and nondominant representational hemisphere with visuospatial relations. Neocortex, Cerebral asymmetry or dominance, Functions of any one lobe of the brain, Cortical plasticity may come as Short Questions. What are the parts of neocortex, Neocortical functions, Concept of cerebral asymmetry, What is the meaning of dominant and nondominant hemisphere, Cerebral asymmetry or dominance, Functions of all the lobes of the brain, Effects of lesion of all the lobes of the brain, Mechanism of cortical plasticity. Appreciate the formation, functions and clinical importance of bloodbrain barrier. Scientist contributed Domenico Cotugno (1736­1822), Italian physician for the first time scientifically described the clinical application of cerebrospinal fluid. He also demon strated the aural canals and labrinthine fluid, and had worked on cerebral embolism. Lateral ventricles are the largest ones that are located symmetrically in the cerebral hemispheres. The third ventricle is located in the diencephalons, and the fourth ventricle is enclosed in the pons and medulla. The two lateral ventricles communicate with the third ventricle through two independent openings called the foramina of Monro. The third ventricle communicates with fourth ventricle through a narrow passage called the aqueduct of Sylvius. The fourth ventricle narrows down caudally as it enters the spinal cord that continues as the central canal in the cord. Each ventricle contains a bunch of epithelial-vascular tissue known as the choroid plexus. Subarachnoid Space the brain and spinal cord are covered by three layers of the connective tissues, called meninges. The innermost layer, which is in close contact with the brain tissue, is called the pia mater. Next to pia mater is the arachnoid D Cotugno 1156 Section 11: Neurophysiology A B. The space between the pia mater and arachnoid mater is called the subarachnoid space, and the space between the arachnoid mater and the dura mater is the subdural space. The major cisterns are: (1) Superior cistern, located dorsal to midbrain, (2) Cerebellomedullary cistern, located between cerebellum and medulla (this is a large one, therefore also called cisterna magna), (3) Pontine cistern, located near pons, and (4) Interpeduncular cistern, located at the cerebral peduncles. The minor cisterns are cistern of the optic disk, cistern of lamina terminalis, cistern of corpus callosum, perimesencephalic cisterns, cistern of lateral sulcus and the lumbar cistern. The lumbar cistern is the large spinal subarachnoid space extending between L2 and S2 vertebra (Clinical Box 141. One opening is in the midline, called the foramen of Magendie and two openings are placed laterally, called the foramen of Luschka. Arachnoid Granulations Arachnoid granulations are a collection of villi that project from the arachnoid into the subdural venous sinuses. Thus, the subarachnoid space communicates with the venous blood through arachnoid granulations. Passive diffusion: the thin-walled vessels of choroid plexuses allow passive diffusion of substances from blood plasma into extracellular space surrounding choroidal cells. Active transport: the choroid epithelium secretes sodium ions by active transport. This is achieved by Na+-K+ pump operating in the apical surface of the plexus that pumps Na+ into the ventricular cavity Communication between Ventricles and Subarachnoid Space the cerebral ventricles communicate with the subarachnoid space through openings (foramens) in the fourth Chapter 141: Cerebrospinal Fluid Table 141. The sodium and chloride ions create the osmotic gradient for flow of water into the ventricles. In the basal surface, chloride is exchanged for bicarbonate, and H+ is exchanged for Na+. Facilitated diffusion: Penetration of substances into brain is directly proportional to their lipid solubility. They enter by facilitated diffusion, which is stereospecific (carrier binds only with a solute having specific configuration). Thus, obstruction of foramen of Monro results in distension of lateral ventricles, occlusion of aqueduct of Sylvius causes distension of third ventricle, and blockage of foramina of Magendie and Luschka initially distends fourth ventricle and later the entire ventricular system is distended. This happens because skull moves with the head along the direction of hit but the brain lags behind slightly due to its inertia. When skull comes to rest, the side of the brain opposite the blow hits the skull due to the combined effect of inertia and vacuum. Neurons in the brain are highly sensitive to changes in oxygen, glucose, pH, temperature, etc. Removal of proteins and waste products: There are no lymphatic channels in brain and spinal cord. Thus, the risk of routine acceleration-deceleration injuries is eliminated and also the impact of major injuries is greatly diminished (Clinical Box 141. Determination of types of cells, and estimations of protein and glucose concentration are very useful. The glucose concentration is low as microorganisms utilize glucose, but protein concentration is high due to increased capillary permeability that increases ultrafiltration of protein. In bacterial meningitis Chapter 141: Cerebrospinal Fluid 1159 polymorphs are more, in tubercular meningitis lymphocytes are more (cob-web appearance due to increased fibrin clot) and in viral meningitis moderate increase occurs in lymphocytes (but no decrease in glucose). Therefore, this is also called obstructive hydrocephalus or high-pressure hydrocephalus. Obstruction of foramen of Monro results in distension of lateral ventricles, obstruction of aqueduct of Sylvius causes distension of third and lateral ventricles, and obstruction of foramina of Magendie and Luschka initially distends fourth ventricle but later enlarges entire ventricular system. The usual finding is the papilledema, and engorgement and edema around the optic disk. The herniation of cerebellum and medulla, the phenomenon also called as coning, damages the vital centers (cardiovascular and respiratory centers) in the medulla leading to sudden cardio-respiratory arrest. If the patient is lying on his side, the pressure ranges from 100 to 180 cm H2O or 7 to 13 mm Hg. Queckenstedt test is performed to demonstrate spinal subarachnoid block, if present. Normally, the rise is rapid up to 100 to 200 mm H2O, and the pressure returns to normal within 10 seconds following release of compression. If the spinal subarachnoid block is present, the rise and fall are slow or absent. Hydrocephalus is usually divided into two categories: communicating and noncommunicating. Communicating hydrocephalus occurs due to damage to arachnoid villi, which commonly happens following infection or inflammation of meninges. Neurons depend on a normal concentration of various ions in the fluid bathing them, especially Na+, K+, Ca++, H+ and Mg++. Many toxins either produced endogenously or administered exogenously circulate in blood. In the endothelium of capillaries of the brain, cells are joined by tight junctions. The capillaries of the choroid plexuses also have tight junctions between the endothelial cells. Therefore, if there is hyperbilirubinemia during infancy, as occurs in hemolytic diseases of newborn like erythroblastosis fetalis, free bilirubin enters the brain and deposited in basal ganglia. New capillaries that develop in the tumor area do not have contact with astrocytes. This anatomical defect aids in diagnosis of the Chapter 141: Cerebrospinal Fluid 1161 tumor. For diagnosis of brain tumor, brain is scanned for radioactivity following injection of a radioactive substance like radioiodinated serum albumin. The hypertonic fluid causes shrinking of the endothelial cells, which in turn makes the tight junctions leaky (less tight). Therefore, just before administration of drugs that are aimed to penetrate brain tissue, a hypertonic solution is injected into the carotid artery. Physiology of Taste "I am the inviolable Ecstasy; Those who have looked on me, shall grieve no more. Eyes are one of the most essential sense organs gifted by the nature to the living species. For the animals to get food, escape from the predator, be aware of far and near objects and find a mate, eyes play a very vital role. In human beings, eyes are not only a means to behold the beauty of the creation, but it helps in recognizing faces of the loved ones that strengthens the emotional and social bond. An optical system that helps to focus and form an image on the receptor cells when light rays being reflected from an object fall on the eye; and ii. A neural system that transmits the optical signal in the form of action potentials along the optic nerve to the visual cortex to be perceived as visual sensation. The optical systems are present in its anterior part and the visual receptors are placed at the posterior surface, from which the optic nerve arises and proceeds towards the occipital cortex. Each eyeball is surrounded by a cushion of fat and is placed within a bony cavity called orbit. The outermost layer is transparent in its anterior part called cornea and the rest opaque area is known as sclera. The middle vascular and pigmented uveal tract forms choroid and ciliary body in its posterior part and iris in its anterior part. The innermost layer is called retina, which contains the photoreceptors in association with a neuronal network that is absent in the anterior segment. The interior of the eyeball is divided into three spaces, anterior chamber, posterior chamber and the posterior 1166 Section 12: Special Senses ii. Stroma or substantia propria: It consists of highly structured thin collagen fibrils in a mucopolysaccharide matrix. The fibrils are of equal diameter, spaced at regular intervals and form a hexagonal lattice that confers transparency to the cornea. In these cases if the vision is grossly impaired, corneal transplantation shows encouraging result. As the cornea is avascular, blood-borne antibodies cannot reach the grafted tissue to cause transplant rejection.